Main Menu
We represent medical device and digital health companies in developing, protecting, and commercializing innovative products, with particular strength advising growth-stage companies as they scale and execute business plans on product development, strategic partnering, and investment transactions.
Procopio represents medical device and digital health companies at every stage of development, with a particular focus on growth-stage and mid-market businesses as they move from product development to commercialization, strategic partnerships, and exit. We work with device manufacturers, diagnostics companies, digital health and precision medicine platforms, and technology-driven healthcare businesses, as well as investors and strategic partners.
Our cross functional legal team integrates intellectual property, corporate, transactions, and litigation capabilities to address the full range of issues that arise in developing and commercializing medical technologies. We advise on patent strategy and portfolio development, licensing and collaboration agreements, financings, mergers and acquisitions, and complex disputes, with a focus on aligning intellectual property with product design, market positioning, and long-term business objectives.
Many of our attorneys have engineering or scientific backgrounds and work directly with product development and business teams for better efficiency and responsiveness.
With a strong California presence and national reach, we support clients in cross-border transactions, manufacturing relationships, and commercialization strategies, delivering practical advice with efficient staffing and consistent senior-level involvement.
We help medical device and digital health companies develop, protect, and leverage intellectual property aligned with product design and commercialization strategy.
We structure and negotiate the agreements that enable companies to bring products to market and scale their business.
We advise companies and investors through formation, financing, and strategic transactions that support growth and long-term value.
We advise companies developing software-enabled medical technologies and data-driven platforms on legal and operational considerations.
We represent medical device and digital health companies in disputes involving intellectual property, commercial relationships, and product-related risks.
We support companies in securing and developing the facilities required for research, development, and manufacturing.
Ideally, early in product development and before key decisions around intellectual property, commercialization, or partnerships are finalized. Early involvement helps ensure that IP is properly protected, product strategy aligns with regulatory and business goals, and agreements support long-term growth.
Medical device and digital health companies are often more product- and engineering-driven, with faster development cycles and earlier commercialization. Legal needs tend to focus on intellectual property, product development, licensing, manufacturing, and market entry, rather than clinical trial frameworks typical in pharmaceutical development.
Intellectual property strategy should be developed alongside product design and commercialization planning, not after. For medical device and digital health companies, this means protecting core functionality, anticipating competitive design-arounds, and building a portfolio that supports licensing, partnerships, and investor expectations. We work with clients to align patent strategy with product evolution, manufacturing considerations, and market positioning to maximize long-term value.
Commercialization typically involves a range of agreements, including licensing, manufacturing, supply, distribution, and strategic partnerships. These agreements define how products are developed, produced, and brought to market, and must align with both IP strategy and business objectives.
As companies grow, legal needs expand beyond IP into transactions, workforce, data, and operational matters. We help clients manage that transition by providing coordinated support across disciplines, with a focus on practical execution and efficient use of resources.
Many modern medical technologies incorporate software, data analytics, and AI. These raise additional considerations around data ownership, privacy, cybersecurity, and regulatory compliance. We help clients integrate these issues into their overall product and commercialization strategy.
California presents unique considerations, particularly in employment law, data privacy, and business regulations. Companies developing digital health or data-driven technologies must also navigate evolving privacy frameworks such as CCPA and CPRA. We help clients manage these requirements while maintaining flexibility for growth.
Yes. We represent medical device and digital health companies, as well as venture capital firms, private equity investors, and strategic partners. This perspective allows us to structure transactions that are commercially realistic and aligned with market expectations.
As companies grow and transactions become more complex, they often seek counsel that can provide broader, integrated support and consistent senior-level involvement. This is especially true for growth-stage and mid-market companies preparing for commercialization, partnerships, or exit.
We staff matters deliberately to align experience and cost with the client’s needs. Senior attorneys remain actively involved in strategy and key decisions, while execution is handled efficiently by the appropriate team members. Our goal is to deliver practical, high-quality advice without unnecessary layers or cost.
18 results found.
Personal, hands-on service
